Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP719840.RAUTA4dr2J4ydsiG1lQFhFKznrkdGDpVGfkeUAwO1W_Wo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP719840.RAUTA4dr2J4ydsiG1lQFhFKznrkdGDpVGfkeUAwO1W_Wo130_assertion type Assertion NP719840.RAUTA4dr2J4ydsiG1lQFhFKznrkdGDpVGfkeUAwO1W_Wo130_head.
- NP719840.RAUTA4dr2J4ydsiG1lQFhFKznrkdGDpVGfkeUAwO1W_Wo130_assertion description "[We used the PKC agonist 1,2-dioctanoylglycerol (DOG) and phorbol myristate acetate (PMA) to activate PKC, calphostin C, and GO 6976, as inhibitors of PKC; phosphatidic acid (PA), which is the product of PLD, and lysophosphatidic acid (LPA), phosphatidylcholine, sphingomyelin, and beta-cyclodextrin to investigate their potential effect in modulating cellular cholesterol efflux in [(3)H]cholesterol-labeled and cholesterol-loaded fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP719840.RAUTA4dr2J4ydsiG1lQFhFKznrkdGDpVGfkeUAwO1W_Wo130_provenance.
- NP719840.RAUTA4dr2J4ydsiG1lQFhFKznrkdGDpVGfkeUAwO1W_Wo130_assertion evidence source_evidence_literature NP719840.RAUTA4dr2J4ydsiG1lQFhFKznrkdGDpVGfkeUAwO1W_Wo130_provenance.
- NP719840.RAUTA4dr2J4ydsiG1lQFhFKznrkdGDpVGfkeUAwO1W_Wo130_assertion SIO_000772 11181755 NP719840.RAUTA4dr2J4ydsiG1lQFhFKznrkdGDpVGfkeUAwO1W_Wo130_provenance.
- NP719840.RAUTA4dr2J4ydsiG1lQFhFKznrkdGDpVGfkeUAwO1W_Wo130_assertion wasDerivedFrom befree-20140225 NP719840.RAUTA4dr2J4ydsiG1lQFhFKznrkdGDpVGfkeUAwO1W_Wo130_provenance.
- NP719840.RAUTA4dr2J4ydsiG1lQFhFKznrkdGDpVGfkeUAwO1W_Wo130_assertion wasGeneratedBy ECO_0000203 NP719840.RAUTA4dr2J4ydsiG1lQFhFKznrkdGDpVGfkeUAwO1W_Wo130_provenance.